Wedbush Securities Inc. Has $9.79 Million Position in UnitedHealth Group Incorporated $UNH

Key Points

• Wedbush Securities reduced its UnitedHealth Group position by 15.3% in the second quarter, leaving it with 23,548 shares valued at approximately $9.79 million. Institutional investors and hedge funds collectively own 87.86% of UNH.
• Wall Street remains broadly positive, with two Strong Buy ratings, 19 Buy ratings and six Holds. The stock has a “Moderate Buy” consensus rating and an average analyst price target of $456.56.
• UnitedHealth exceeded quarterly expectations with adjusted earnings of $6.38 per share and revenue of $112.03 billion, while maintaining 2026 EPS guidance of $19.50–$20.00. The company also declared a quarterly dividend of $2.32 per share, representing a 2.4% annualized yield.

Wedbush Securities Inc. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 15.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 23,548 shares of the healthcare conglomerate's stock after selling 4,242 shares during the quarter. Wedbush Securities Inc.'s holdings in UnitedHealth Group were worth $9,787,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of UNH. Norges Bank bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $4,376,167,000. Corient Private Wealth LP bought a new position in shares of UnitedHealth Group in the second quarter worth about $245,516,000. Legal & General Group Plc bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at approximately $2,444,928,000. Jupiter Topco LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at approximately $2,019,844,000. Finally, BlackRock Inc. grew its stake in shares of UnitedHealth Group by 4.6% during the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock worth $31,946,594,000 after buying an additional 3,395,530 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research reports. HC Wainwright set a $492.00 price objective on UnitedHealth Group in a research report on Wednesday, May 27th. Royal Bank Of Canada lifted their price target on UnitedHealth Group from $463.00 to $478.00 and gave the company an "outperform" rating in a research note on Friday, July 17th. Barclays raised their price objective on shares of UnitedHealth Group from $429.00 to $441.00 and gave the company an "overweight" rating in a report on Monday, July 20th. Robert W. Baird upgraded shares of UnitedHealth Group from an "underperform" rating to a "neutral" rating and upped their price target for the company from $287.00 to $453.00 in a research report on Thursday, July 16th. Finally, JPMorgan Chase & Co. lifted their price target on shares of UnitedHealth Group from $466.00 to $516.00 and gave the stock an "overweight" rating in a report on Tuesday, July 21st. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average target price of $456.56.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $393.99 on Friday. The stock has a market capitalization of $353.64 billion, a PE ratio of 25.35, a PEG ratio of 1.36 and a beta of 0.62. The business's 50 day simple moving average is $413.28 and its 200 day simple moving average is $360.11. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. During the same quarter in the previous year, the company earned $4.08 EPS. The company's revenue for the quarter was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be given a $2.32 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group's dividend payout ratio (DPR) is 59.72%.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 1,169 shares of the firm's stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company's stock, valued at $5,977,920. This trade represents a 7.09% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 0.19% of the stock is currently owned by insiders.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source